Clinical Trial: Empagliflozin Treatment in Kidney Transplant Recipients
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Kidney Transplant
Study Type: INTERVENTIONAL
Official Title: An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)
Brief Summary:
Kidney transplantation improves the health and quality of life for those Veterans with end stage kidney disease (ESKD).While early patient and graft survival are excellent, long-term outcomes continue to be challenging.Patient death with existing kidney graft function occurs in about half of all recipients over time.This is primarily due to the development of cardiovascular disease in a patient population with multiple preexisting cardiac disease risk factors.There has been little progress in improving outcomes in…
Read more